143 related articles for article (PubMed ID: 27891622)
1. Safety evaluation of orally administered afoxolaner and milbemycin oxime in eight-week-old dogs.
Drag M; Saik J; Harriman J; Letendre L; Yoon S; Larsen D
J Vet Pharmacol Ther; 2017 Oct; 40(5):447-453. PubMed ID: 27891622
[TBL] [Abstract][Full Text] [Related]
2. Safety evaluation of orally administered afoxolaner in 8-week-old dogs.
Drag M; Saik J; Harriman J; Larsen D
Vet Parasitol; 2014 Apr; 201(3-4):198-203. PubMed ID: 24629431
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of oral afoxolaner plus milbemycin oxime chewables against induced gastrointestinal nematode infections in dogs.
Fankhauser R; Hamel D; Dorr P; Reinemeyer CR; Crafford D; Bowman DD; Ulrich M; Yoon S; Larsen DL
Vet Parasitol; 2016 Jul; 225():117-22. PubMed ID: 27369586
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of afoxolaner plus milbemycin oxime chewable tablets (NexGard Spectra
Tielemans E; Lebon W; Dumont P; Taweethavonsawat P; Larsen D; Rehbein S
Vet Parasitol; 2017 Apr; 238():87-89. PubMed ID: 28408213
[TBL] [Abstract][Full Text] [Related]
5. Monthly administrations of milbemycin oxime plus afoxolaner chewable tablets to prevent Angiostrongylus vasorum infection in dogs.
Lebon W; Tielemans E; Rehbein S; Dumont P; Yoon S; Beugnet F; Jeannin P; Larsen D; Halos L
Parasit Vectors; 2016 Sep; 9(1):485. PubMed ID: 27589951
[TBL] [Abstract][Full Text] [Related]
6. The intravenous and oral pharmacokinetics of afoxolaner and milbemycin oxime when used as a combination chewable parasiticide for dogs.
Letendre L; Harriman J; Drag M; Mullins A; Malinski T; Rehbein S
J Vet Pharmacol Ther; 2017 Jan; 40(1):35-43. PubMed ID: 27604405
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of afoxolaner plus milbemycin oxime chewable tablets against naturally acquired intestinal nematodes in dogs.
Rehbein S; Dorr P; Bowman DD; Crafford D; Kusi I; Postoli R; Yoon S; Chester ST; Dollhofer D; Visser M; Larsen DL
Vet Parasitol; 2016 Feb; 217():29-35. PubMed ID: 26827857
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the efficacy of monthly oral administration of afoxolaner plus milbemycin oxime (NexGard Spectra(®), Merial) in the prevention of adult Spirocerca lupi establishment in experimentally infected dogs.
Beugnet F; Crafford D; de Vos C; Kok D; Larsen D; Fourie J
Vet Parasitol; 2016 Aug; 226():150-61. PubMed ID: 27514901
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of oral afoxolaner plus milbemycin oxime chewables against induced infestations with Dermacentor reticulatus in dogs.
Rehbein S; Fourie JJ; de Vos C; Anderson A; Larsen DL; Jeannin P
Parasitol Res; 2016 May; 115(5):1845-51. PubMed ID: 26815036
[TBL] [Abstract][Full Text] [Related]
10. Efficacy against nematode infections and safety of afoxolaner plus milbemycin oxime chewable tablets in domestic dogs under field conditions in Europe.
Rehbein S; Knaus M; Mallouk Y; Breiltgens T; Brianti E; Capári B; Dantas-Torres F; Gau M; Joachim A; Kaulfuß KH; Kirkova Z; Lechner J; Mihalca AD; Mirabito R; Petkevičius S; Rapti D; Shukullari E; Sedeilhan M; Dollhofer D; Kley K; Lebon W; Visser M; Jeannin P
Parasitol Res; 2017 Jan; 116(1):259-269. PubMed ID: 27771803
[TBL] [Abstract][Full Text] [Related]
11. Safety of an oral combination of moxidectin, afoxolaner, and pyrantel pamoate in dogs.
Drag M; Tielemans E; Mitchell E; McCall JW; Targa N; Bruner R; Yoon S; Colley B; Fankhauser B
Res Vet Sci; 2024 Jun; 173():105271. PubMed ID: 38631075
[TBL] [Abstract][Full Text] [Related]
12. Safety of oral afoxolaner formulated with or without milbemycin oxime in homozygous MDR1-deficient collie dogs.
Drag M; Tielemans E; Mitchell E
J Vet Pharmacol Ther; 2022 Jul; 45(4):373-379. PubMed ID: 35536118
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of afoxolaner plus milbemycin oxime and afoxolaner alone as treatment for sarcoptic mange in naturally infested dogs.
Romero-Núñez C; Bautista-Gómez LG; Sheinberg G; Martín-Cordero A; Flores-Ortega A; Heredia-Cárdenas R
Can J Vet Res; 2020 Jul; 84(3):212-216. PubMed ID: 32801456
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of afoxolaner or the combination of afoxolaner with milbemycin oxime against Otodectes cynotis in naturally infested dogs.
Sioutas G; Papadopoulos E; Madder M; Beugnet F; Tielemans E
Vet Parasitol; 2024 Feb; 326():110108. PubMed ID: 38154391
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of milbemycin oxime/afoxolaner chewable tablets (NEXGARD SPECTRA
Di Cesare A; Morelli S; Morganti G; Simonato G; Veronesi F; Colombo M; Berlanda M; Lebon W; Gallo M; Beugnet F; Traversa D
Parasit Vectors; 2021 Mar; 14(1):143. PubMed ID: 33676579
[TBL] [Abstract][Full Text] [Related]
16. Treatment of canine sarcoptic mange with afoxolaner (NexGard
Hampel V; Knaus M; Schäfer J; Beugnet F; Rehbein S
Parasite; 2018; 25():63. PubMed ID: 30516132
[TBL] [Abstract][Full Text] [Related]
17. The intravenous and oral pharmacokinetics of afoxolaner used as a monthly chewable antiparasitic for dogs.
Letendre L; Huang R; Kvaternick V; Harriman J; Drag M; Soll M
Vet Parasitol; 2014 Apr; 201(3-4):190-7. PubMed ID: 24685320
[TBL] [Abstract][Full Text] [Related]
18. Six-month field efficacy and safety of the combined treatment of dogs with Frontline Tri-Act® and NexGard Spectra®.
Abbate JM; Napoli E; Arfuso F; Gaglio G; Giannetto S; Halos L; Beugnet F; Brianti E
Parasit Vectors; 2018 Jul; 11(1):425. PubMed ID: 30012179
[TBL] [Abstract][Full Text] [Related]
19. Long-term and acute safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio
Riggs KL; Wiseman S
Parasit Vectors; 2021 May; 14(1):285. PubMed ID: 34044853
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the curative and preventive efficacy of a single oral administration of afoxolaner against cat flea Ctenocephalides felis infestations on dogs.
Hunter JS; Dumont P; Chester TS; Young DR; Fourie JJ; Larsen DL
Vet Parasitol; 2014 Apr; 201(3-4):207-11. PubMed ID: 24629423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
